Completion of DLT observation period for Cohort 1; first patient in Cohort 2 dosed at higher cell level; additional dosing in Cohort 1 SOUTH SAN FRANCISCO, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces recent advances to the CertainT-1 trial that is focused on patients with acute myeloid leukemia (AML). Following completion of the ...

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SAGA Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H), a North American exploration company advancing critical mineral discoveries, is pleased to announce the full logging of all eight drill holes completed in the Trapper zone and confirms shipping three additional holes to IGS’s lab for analysis. Additionally, important new structural data in Trapper South’s R-0014 have been identified, providing valuable insights i ...

The $5 million investment into MAX Power from a leading conglomerate in Vietnam has officially closed and launches an international collaboration focused on accelerating Natural Hydrogen development in Saskatchewan, positioning Canada at the forefront of a new clean energy frontier. Video: Lawson – Canada’s First Big Step into Natural Hydrogen https://www.youtube.com/watch?v=lTTOwMxz_zo SASKATOON, Saskatchewan, Dec. 17, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) ...

ROCKVILLE, Md. and SUZHOU, China, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced today that the Company’s management plans to present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. T ...

Minneapolis, MN, Dec. 17, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world’s largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that effective December 15, 2025 its Board of Directors has appointed Joseph Chalom as sole Chief Executive Officer and elected him to the Board. Rob Phythian has stepped down from his roles as Co-Chief Executive Officer and Director, marking the completion o ...

SOMERSET, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the company’s Chief Executive Officer, will present the latest company updates at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14th, 2026, at 9:00 a.m. PT. The live webcast will be available to investors and other interested parties by accessing the Investor Relations section of ...

Following closing, combined company plans to progress Yarrow’s lead program, YB-101, a potentially first-in-class anti-thyroid-stimulating hormone receptor (“TSHR”) antibody for Graves’ disease (“GD”) and thyroid eye disease (“TED”)Yarrow Bioscience is the seventh biotechnology company founded by RTW Investments and plans to advance in-licensed asset YB-101 (also known as GS-098) into a U.S.-based Phase 1b/2b trial in patients with GD in the first half of 2026; a Phase 1 trial in TED is being conducted in C ...

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will integrate in-patient training and rehabilitation to support clinical adoption in physical rehabilitation settings Over 7 million survivors of spinal cord injury (SCI) globally could potentially benefit from ReWalk, an estimated $1.75 billion total addressable market for Lifeward MARLBOROUGH, Mass., YOKNEAM ILLIT,  ...

GREENWICH, Conn., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds, LLC (“Gabelli”) today announced that all its actively managed ETFs are now fully transparent. These Gabelli ETFs complement the firm’s long-standing investment offerings across mutual funds, closed-end funds, and separate accounts – providing additional ways for advisors and investors to access Gabelli’s fundamental, bottom-up research across a range of equity and income approaches. Effective today, Gabelli offers the following seven fully t ...

核心观点 - 公司宣布了截至2025年6月30日的六个月期初步财务业绩 并概述了加速成为全球身份、安全数据和受监管人工智能的信任基础设施的战略 [1] - 业绩反映了公司在强化运营状况、改善利润率结构以及推进资产负债表稳定计划方面取得的重大进展 [2] - 管理层认为 公司基本面比近年来任何时候都更加强劲 其价值由正在构建的架构驱动 而非短期股价波动 [8][9] 财务与运营亮点 - **营收与利润率**：2025年上半年营收为1510万美元 毛利率大幅提升至23% 较去年的10%实现翻倍以上增长 这反映了公司向高利润率产品的结构性转型 [6] - **资产与权益**：总资产增至7300万美元 反映了合并后整合了Blackswan的知识产权和平台技术 股东权益（赤字）从2024年12月31日的（8100万美元）改善至2025年6月30日的（5900万美元） [6] - **流动性增强**：期内后流动性得到增强 包括1332万美元的新现金收益 今年以来 公司已延长、和解及/或清偿了2285万美元的历史债务 重组了超过75%的历史债务 [6] - **资本结构行动**：公司执行了一系列协调的资本结构和资产负债表行动 旨在减少短期债务、延长到期期限并提高财务可见性 [6] 战略定位与资产基础 - **资产基础**：公司资产基础目前包括约4000万美元的合并知识产权和技术资产 构成了其安全数据结构和信任基础设施平台的基础 [6] - **目标市场**：公司认为这些资产加强了其在高度监管行业（包括金融服务、政府和关键基础设施）的长期定位 在这些领域 安全数据虚拟化和合规驱动的架构日益重要 [6][7] - **公司愿景**：数字经济正将信任作为其核心基础设施层 公司正在将身份、数据安全和人工智能治理统一为一个为机构和国家级运营设计的单一信任架构 [10] 遗留问题解决与运营改善 - **历史争议解决**：2025年11月 公司达成和解协议 解决了源于2023年业务合并的历史PIPE相关争议 和解几乎不产生现金影响 消除了重大的历史不确定性和潜在诉讼风险 [5] - **运营改善**：毛利率的提升源于向高利润率产品的刻意转型、更严格的运营纪律以及重新设计的交付经济模式 这为公司的可扩展增长奠定了基础 [6] - **管理层评论**：公司在2025年上半年重建了基础 扩大了利润率、增强了流动性并消除了历史遗留限制 这些改进是结构性的 将使公司未来能够以更强的纪律性、规模和财务韧性运营 [8]